Biotechnology
New patent for Nexus Pharms drug EMERPHED – DrugPatentWatch
Copyright © DrugPatentWatch. Originally published in New patent for Nexus Pharms EMERPHED drug
Annual Drug Patent Expiration for EMERPHED
Emerphed is a drug marketed by Nexus Pharms and included in one NDA. It is available from a single supplier. There are four patents protecting this drug.
This drug has eight patent family members in eight countries.
The generic ingredient in EMERPHED is ephedrine sulfate. One registered supplier for this compound. Additional details are available on the ephedrine sulfate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
Make Better Decisions with DrugPatentWatch
» Start Your Free Trial Today «
Copyright © DrugPatentWatch. Originally published in New patent for Nexus Pharms EMERPHED drug
